Influence of Serum Vitamin D Level in the Response of Actinic Keratosis to Photodynamic Therapy with Methylaminolevulinate.

actinic keratosis calcitriol methylaminolevulinate photochemotherapy vitamin d vitamin d receptor

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
01 Feb 2020
Historique:
received: 16 12 2019
revised: 17 01 2020
accepted: 25 01 2020
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 7 2 2020
Statut: epublish

Résumé

In mouse models of squamous cell carcinoma, pre-treatment with calcitriol prior to photodynamic therapy with aminolevulinic acid (ALA) enhances tumor cell death. We have evaluated the association between vitamin D status and the response of actinic keratoses to photodynamic therapy with methylaminolevulinate. Twenty-five patients with actinic keratoses on the head received one session of photodynamic therapy with methylaminolevulinate. Biopsies were taken at baseline and six weeks after treatment. Immuno-histochemical staining was performed for VDR, P53, Ki67 and -catenin. Basal serum 25(OH)D levels were determined. Cases with a positive histological response to treatment had significantly higher serum 25(OH)D levels (26.96 (SD 7.49) ngr/mL) than those without response (18.60 (SE 7.49) ngr/mL) (

Identifiants

pubmed: 32024208
pii: jcm9020398
doi: 10.3390/jcm9020398
pmc: PMC7073858
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Br J Dermatol. 2011 Jul;165(1):144-51
pubmed: 21615716
Photodiagnosis Photodyn Ther. 2018 Mar;21:172-175
pubmed: 29203353
J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):567-70
pubmed: 15225840
J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1303-7
pubmed: 26955898
Br J Dermatol. 2007 May;156 Suppl 3:8-12
pubmed: 17488400
Cancers (Basel). 2013 Nov 05;5(4):1426-38
pubmed: 24202452
Photochem Photobiol. 2014 Sep-Oct;90(5):1126-35
pubmed: 24807677
Cancer Res. 2011 Sep 15;71(18):6040-50
pubmed: 21807844
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:237-41
pubmed: 24239508
Recent Results Cancer Res. 2003;164:259-69
pubmed: 12899528
Exp Mol Pathol. 2014 Feb;96(1):42-7
pubmed: 24239751
Adv Exp Med Biol. 2014;810:282-302
pubmed: 25207372
J Invest Dermatol. 2005 Apr;124(4):778-85
pubmed: 15816836
Br J Dermatol. 2018 Oct;179(4):829-835
pubmed: 29476546
Front Endocrinol (Lausanne). 2012 Apr 23;3:58
pubmed: 22649423
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Front Physiol. 2014 Jun 03;5:166
pubmed: 24917821
Proc SPIE Int Soc Opt Eng. 2015 Mar 2;9308:93080Q
pubmed: 25983370
Cancer Causes Control. 2005 Mar;16(2):83-95
pubmed: 15868450
J Photochem Photobiol B. 2016 Jan;154:34-9
pubmed: 26678673

Auteurs

Ricardo Moreno (R)

Dermatology Service, Hospital Univ. del Henares, Coslada, 28822 Madrid, Spain.

Laura Nájera (L)

Pathology Service, Hospital Puerta de Hierro, Majadahonda, 28222 Madrid, Spain.

Marta Mascaraque (M)

Department of Cellular Biology. Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Ángeles Juarranz (Á)

Department of Cellular Biology. Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Salvador González (S)

Medicine and Medical Specialties Department, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS),Universidad de Alcalá, 28034 Madrid, Spain.

Yolanda Gilaberte (Y)

Dermatology Service. Hospital Univ. Miguel Servet, 50009 Zaragoza, Spain.

Classifications MeSH